Central nervous system oxygen toxicity and hyperbaric oxygen seizuresz

Aerospace Medicine and Human Performance

Volumn 87, Issue 5, 2016, Pages 477-486

  Manning, Edward P ^a  

^a HOSPITAL OF THE UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

CNS oxygen toxicity; Hyperbaric oxygen seizures; Hyperbaric oxygen therapy

Indexed keywords

REACTIVE OXYGEN METABOLITE;

ADVERSE EFFECTS; HUMAN; HYPERBARIC OXYGEN; METABOLISM; RISK FACTOR; SEIZURES;

HUMANS; HYPERBARIC OXYGENATION; REACTIVE OXYGEN SPECIES; RISK FACTORS; SEIZURES;

EID: 84973440871     PISSN: 23756314     EISSN: 23756322     Source Type: Journal    
DOI: 10.3357/AMHP.4463.2016     Document Type: Article

References (126)

1. Allen BW, Demchenko IT, Piantadosi CA. Two faces of nitric oxide: implications for cellular mechanisms of oxygen toxicity. J Appl Physiol. 2009 Feb 106(2):662-667.
2. Arieli R. Oxygen toxicity is not related to mammalian body size. Comp Biochem Physiol A Comp Physiol. 1988; 91(2):221-223.
3. Arieli R, Arieli Y, Daskalovic Y, Eynan M, Abramovich A. CNS oxygen toxicity in closed-circuit diving: signs and symptoms before loss of consciousness. Aviat Space Environ Med. 2006; 77(11):1153-1157.
4. Beckman DL, Crittenden DJ, Overton 3rd DH, Blumenthal SJ. Influence of blood glucose on convulsive seizures from hyperbaric oxygen. Life Sci. 1982; 31(1):45-49.
5. Beckman DL, Iams SG. Protection against high-pressure oxygen seizures by amino-oxyacetic acid. Undersea Biomed Res. 1978 Sep 5(3):253-257.
6. Benjamini Y, Bitterman N. Statistical approach to the analysis of sensitivity to CNS oxygen toxicity in rats. Undersea Biomed Res. 1990 May 17(3):213-221.
7. Bertelli A, Giovannini L, Mian M, Spaggiari PG. Protective action of propionyl-L-carnitine on toxicity induced by hyperbaric oxygen. Drugs Exp Clin Res. 1990; 16(10):527-530.
8. Bertelli A, Bertelli AA, Giovannini L, Spaggiari P. Protective synergic effect of coenzyme Q10 and carnitine on hyperbaric oxygen toxicity. Int J Tissue React. 1990; 12(3):193-196.
9. Bitterman N, Laor A, Melamed Y. CNS oxygen toxicity in oxygen-inert gas mixtures. Undersea Biomed Res. 1987 Nov 14(6):477-483.
10. Bitterman N, Melamed Y, Ben-Amotz A. Beta-carotene and CNS oxygen toxicity in rats. J Appl Physiol (1985). 1994 Mar 76(3):1073-1076.
11. Bitterman N. CNS oxygen toxicity. Undersea Hyperb Med. 2004; 31(1):63-72.
12. Bitterman N, Bitterman H. L-arginine-NO pathway and CNS oxygen toxicity. J Appl Physiol (1985). 1998; 84(5):1633-1638.
13. Bitterman N, Schaal S. Caffeine attenuates CNS oxygen toxicity in rats. Brain Res. 1995; 696(1-2):250-3.
14. Bleiberg B, Kerem D. Central nervous system oxygen toxicity in the resting rat: postponement by intermittent oxygen exposure. Undersea Biomed Res. 1988 Sep 15(5):337-52.
15. Block ER. Effect of superoxide dismutase and succinate on the development of hyperbaric oxygen toxicity. Aviat Space Environ Med. 1977 Jul 48(7):645-8.
16. Boerema I, Kroll JA, Meijne NG, Lobin E, Kroom B, Huskies JW. High atmospheric pressure as an aid to cardiac surgery. Arch Chir Neerl. 1956; 8:193-211.
17. Camporesi EM, Bosco G. Mechanisms of action of hyperbaric oxygen therapy. Undersea Hyperb Med. 2014; 41(3):247-252.
18. Camporesi EM. Side effects of hyperbaric oxygen therapy. Undersea Hyperb Med. 2014; 41(3):253-257.
19. Carreau A, El Hafny-Rahbi B, Matejuk A, Grillon C, Kieda C. Why is the partial oxygen pressure of human tissues a crucial parameter? Small molecules and hypoxia. J Cell Mol Med. 2011; 15(6):1239-1253.
20. Chavko M, Auker CR, McCarron RM. Relationship between protein nitration and oxidation and development of hyperoxic seizures. Nitric Oxide. 2003 Aug 9(1):18-23.
21. Chavko M, Braisted JC, Harabin AL. Attenuation of brain hyperbaric oxygen toxicity by fasting is not related to ketosis. Undersea Hyperb Med. 1999; 26(2):99-103.
22. Chavko M, Braisted JC, Harabin AL. Effect of MK-801 on seizures induced by exposure to hyperbaric oxygen: comparison with AP-7. Toxicol Appl Pharmacol. 1998; 151(2):222-228.
23. Chavko M, Braisted JC, Outsa NJ, Harabin AL. Role of cerebral blood flow in seizures from hyperbaric oxygen exposure. Brain Res. 1998; 791(1-2):75-82.
24. Chavko M, McCarron RM. Extension of brain tolerance to hyperbaric O2 by intermittent air breaks is related to the time of CBF increase. Brain Res. 2006; 1084(1):196-201.
25. Chavko M, Nadi NS, Keyser DO. Activation of BDNF mRNA and protein after seizures in hyperbaric oxygen: implications for sensitization to seizures in re-exposures. Neurochem Res. 2002; 27(12):1649-1653.
26. Chavko M, Xing G, Keyser DO. Increased sensitivity to seizures in repeated exposures to hyperbaric oxygen: role of NOS activation. Brain Res. 2001; 900(2):227-233.
27. Choi DW, Maulucci-Gedde M, Kriegstein AR. Glutamate neurotoxicity in cortical cell culture. J Neurosci. 1987 Feb 7(2):357-368.
28. Clark JM. Extension of oxygen tolerance by interrupted exposure. Undersea Hyperb Med. 2004; 31(2):195-198.
29. Clark JM. The toxicity of oxygen. Am Rev Respir Dis. 1974;110(6, Pt 2): 40-50.
30. Colton CA, Colton JS. Blockade of hyperbaric oxygen induced seizures by excitatory amino acid antagonists. Can J Physiol Pharmacol. 1985; 63(5):519-521.
31. D'Agostino DP, Pilla R, Held HE, Landon CS, Puchowicz M, et al. Therapeutic ketosis with ketone ester delays central nervous system oxygen toxicity seizures in rats. Am J Physiol Regul Integr Comp Physiol. 2013; 304(10):R829-R836.
32. D'Agostino Dias M, Fontes B, Poggetti RS, Birolini D. Hyperbaric oxygen therapy: types of injury and number of sessions-a review of 1506 cases. Undersea Hyperb Med. 2008; 35(1):53-60.
33. Daniels S. Cellular and neurophysiological effects of high ambient pressure. Undersea Hyperb Med. 2008; 35(1):11-19.
34. Davis JC, Hunt TK, editors. Hyperbaric oxygen therapy. Bethesda (MD): Undersea Medical Society, Inc.; 1977.
35. Davison AJ. Aminooxyacetic acid provides transient protection against seizures induced by hyperbaric oxygen. Brain Res. 1983; 276(2):384-387.
36. Dawson VL, Dawson TM, Bartley DA, Uhl GR, Snyder SH. Mechanisms of nitric oxide-mediated neurotoxicity in primary brain cultures. J Neurosci. 1993; 13(6):2651-2661.
37. Dean JB, Mulkey DK, Garcia AJ, Putnam RW, Henderson RA. Neuronal sensitivity to hyperoxia, hypercapnia, and inert gases at hyperbaric pressures. J Appl Physiol (1985). 2003; 95:883-909.
38. Demchenko IT, Piantadosi CA. Nitric oxide amplifies the excitatory to inhibitory neurotransmitter imbalance accelerating oxygen seizures. Undersea Hyperb Med. 2006; 33(3):169-174.
39. Demchenko IT, Boso AE, O'Neill TJ, Bennett PB, Piantadosi CA. Nitric oxide and cerebral blood flow responses to hyperbaric oxygen. J Appl Physiol (1985). 2000; 88(4):1381-1389.
40. Demchenko IT, Gasier HG, Zhilyaev SY, Moskvin AN, Krivchenko AI, et al. Baroreceptor afferents modulate brain excitation and influence susceptibility to toxic effects of hyperbaric oxygen. J Appl Physiol (1985). 2014; 117(5):525-534.
41. Demchenko IT, Ruehle A, Allen BW, Vann RD, Piantadosi CA. Phosphodiesterase-5 inhibitors oppose hyperoxic vasoconstriction and accelerate seizure development in rats exposed to hyperbaric oxygen. J Appl Physiol (1985). 2009 Apr 106(4):1234-1242.
42. Domachevsky L, Rachmany L, Barak Y, Rubovitch V, Abramovich A, Pick CG. Hyperbaric oxygen-induced seizures cause a transient decrement in cognitive function. Neuroscience. 2013; 247:328-334.
43. Donald K. Oxygen and the diver. West Palm Beach (FL): Best Publishing Co.; 1995.
44. EckenhoffRG, Dougherty JH, Jr., Messier AA, Osborne SF, Parker JW. Progression of and recovery from pulmonary oxygen toxicity in humans exposed to 5 ATA air. Aviat Space Environ Med. 1987 Jul 58(7):658-667.
45. Eynan M, Krinsky N, Biram A, Arieli Y, Arieli R. A comparison of factors involved in the development of central nervous system and pulmonary oxygen toxicity in the rat. Brain Res. 2014; 1574:77-83.
46. Faiman MD, Nolan RJ, Baxter CF, Dodd DE. Brain gamma-aminobutyric acid, glutamic acid decarboxylase, glutamate, and ammonia in mice during hyperbaric oxygenation. J Neurochem. 1977 Apr 28(4):861-865.
47. Faiman MD, Nolan RJ, Oehme FW. Effect of disulfiram on oxygen toxicity in beagle dogs. Aerosp Med. 1974 Jan 45(1):29-32.
48. Fenton LH, Robinson MB. Repeated exposure to hyperbaric oxygen sensitizes rats to oxygen-induced seizures. Brain Res. 1993; 632(1-2): 143-9.
49. Fock AW. Analysis of recreational closed-circuit rebreather deaths 1998-2010. Diving Hyperb Med. 2013; 43:78-85.
50. Garcia AJ 3rd, Putnam RW, Dean JB. Hyperbaric hyperoxia and normobaric reoxygenation increase excitability and activate oxygeninduced potentiation in CA1 hippocampal neurons. J Appl Physiol (1985). 2010;109(3):804-819.
51. Gutsaeva DR, Moskvin AN, Zhiliaev SIu, Kostkin VB, Demchenko IT. [Nitric oxide and carbon dioxide in neurotoxicity induced by oxygen under pressure]. [Article in Russian]. Ross Fiziol Zh Im I M Sechenova. 2004; 90(4):428-436.
52. Hampson NB, Simonson SG, Kramer CC, Piantadosi CA. Central nervous system oxygen toxicity during hyperbaric treatment of patients with carbon monoxide poisoning. Undersea Hyperb Med. 1996 Dec 23(4):215-219.
53. Hall AA, Young C, Bodo M, Mahon RT. Vigabatrin prevents seizure in swine subjected to hyperbaric hyperoxia. J Appl Physiol (1985). 2013; 115(6):861-867.
54. Harris JW, Shrieve DC. Misonidazole (Ro-07-0582) sensitizes mice to convulsions induced by hyperbaric oxygen or pentylenetetrazol. Br J Radiol. 1978; 51(612):1024-1025.
55. Hendricks PL, Hall DA, Hunter WL, Jr., Haley PJ. Extension of pulmonary O2 tolerance in man at 2 ATA by intermittent O2 exposure. J Appl Physiol Respir Environ Exerc Physiol. 1977; 42(4):593-599.
56. Hetz SK, Bradley TJ. Insects breathe discontinuously to avoid oxygen toxicity. Nature. 2005; 433(7025):516-519.
57. Hoppe SA, Terrell DJ, Gottlieb SF. The effect of allopurinol on oxygeninduced seizures in mice. Aviat Space Environ Med. 1984; 55(10): 927-930.
58. Hori S. Study on hyperbaric oxygen-induced convulsion with particular reference to gamma-aminobutyric acid in synaptosomes. J Biochem. 1982; 91(2):443-448.
59. Jacobi Medical Center Hyperbaric Treatments [Internet]. Jacobi Medical Center, Bronx, NY; c2015 [cited 2015 Dec 15]. Available from: http://www.jacobi-hyperbaric.com/html/hyperbaric-treatments.html.
60. Jellestad FK, Gundersen H. Behavioral effects of 7-nitroindazole on hyperbaric oxygen toxicity. Physiol Behav. 2002; 76(4-5):611-616.
61. Jenkinson SG. Oxygen toxicity. New Horiz. 1993; 1(4):504-511.
62. Jenkinson SG, Jordan JM, Duncan CA. Effects of selenium deficiency on glutathione-induced protection from hyperbaric hyperoxia in rat. Am J Physiol. 1989; 257(6, Pt 1):L393-L398.
63. Kandel ER, Schwartz JH, Jessell TM. Principles of neuroscience, 4th ed. Columbus (OH): McGraw-Hill; 2000.
64. Kindwall EP, Whalen HT. Hyperbaric medicine practice, 2nd ed. Flagstaff(AZ): Best Publishing Company; 2004.
65. King GL, Parmentier JL. Oxygen toxicity of hippocampal tissue in vitro. Brain Res. 1983; 260(1):139-142.
66. Koch AE, Koch I, Kowalski J, Schipke JD, Winkler BE, et al. Physical exercise might influence the risk of oxygen-induced acute neurotoxicity. Undersea Hyperb Med. 2013; 40(2):155-163.
67. Kranke P, Bennett MH, Martyn-St James M, Schnabel A, Debus SE, Weibel S. Hyperbaric oxygen therapy for chronic wounds. Cochrane Database Syst Rev. 2015; 6:CD004123.
68. Kurasako T, Takeda Y, Hirakawa M. Increase in cerebral blood flow as a predictor of hyperbaric oxygen-induced convulsion in artificially ventilated rats. Acta Med Okayama. 2000; 54(1):15-20.
69. Lambertsen CJ. Definition of Oxygen Tolerance in Man [Internet]. Institute For Environmental Medicine, University of Pennsylvania Medical Center Philadelphia, PA 19104-6068; Naval Medical Research and Development Command and Office of Naval Research 31 December 1987. C2015 [cited 2015 Dec 12] Available from: http://www.dtic.mil/dtic/tr/fulltext/u2/a239247.pdf.
70. Lee CH, Lee L, Yang KJ, Lin TF. Top-cited articles on hyperbaric oxygen therapy published from 2000 to 2010. Undersea Hyperb Med. 2012; 39(6):1089-1098.
71. Lembeck F, Beubler E. Convulsions induced by hyperbaric oxygen: inhibition by phenobarbital, diazepam and baclofen. Naunyn Schmiedebergs Arch Pharmacol. 1977; 297(1):47-51.
72. Li Q, Guo M, Xu X, Xiao X, Xu W, et al. Rapid decrease of GAD 67 content before the convulsion induced by hyperbaric oxygen exposure. Neurochem Res. 2008; 33(1):185-193.
73. Lin Y, Jamieson D. Are leukotrienes or PAF involved in hyperbaric oxygen toxicity? Agents Actions. 1993; 38(1-2):66-75.
74. Lin Y, Jamieson D. Effects of antioxidants on oxygen toxicity in vivo and lipid peroxidation in vitro. Pharmacol Toxicol. 1992; 70(4):271-277.
75. Liu W, Li J, Sun X, Liu K, Zhang JH, et al. Repetitive hyperbaric oxygen exposures enhance sensitivity to convulsion by upregulation of eNOS and nNOS. Brain Res. 2008; 1201:128-134.
76. Lynch JW. Molecular structure and function of the glycine receptor chloride channel. Physiol Rev. 2004; 84(4):1051-1095.
77. Mayevsky A, Shaya B. Factors affecting the development of hyperbaric oxygen toxicity in the awake rat brain. J Appl Physiol. 1980; 49(4): 700-707.
78. Mendzheritskii AM, Lysenko AV, Uskova NI, Sametskii EA. [The mechanism of the anticonvulsive effect of the delta sleep-inducing peptide under conditions of elevated oxygen pressure]. [Article in Russian, Abstract in English]. Fiziol Zh Im I M Sechenova. 1996; 82(1):59-64.
79. Medicare definition and indications for hyperbaric oxygen therapy [Internet]. c2015 [cited 2015 Nov 11]. Available from: https://www.medicare.gov/coverage/hyperbaric-oxygen-therapy.html.
80. Mialon P, Gibey R, Bigot JC, Barthelemy L. Changes in striatal and cortical amino acid and ammonia levels of rat brain after one hyperbaric oxygen-induced seizure. Aviat Space Environ Med. 1992; 63(4): 287-291.
81. Mialon P, Joanny P, Gibey R, Cann-Moisan C, CaroffJ, et al. Amino acids and ammonia in the cerebral cortex, the corpus striatum and the brain stem of the mouse prior to the onset and after a seizure induced by hyperbaric oxygen. Brain Res. 1995; 676(2):352-357.
82. Moskvin AN, Zhilyaev SY, Sharapov OI, Platonova TF, Gutsaeva DR, et al. Brain blood flow modulates the neurotoxic action of hyperbaric oxygen via neuronal and endothelial nitric oxide. Neurosci Behav Physiol. 2003; 33(9):883-888.
83. Naval Sea Systems Command, United States Department of the Navy. Navy diving manual, 5th ed. Washington (DC): U.S. Government Printing Office; 2005.
84. National Coverage Determination (NCD) for Hyperbaric Oxygen Therapy. (20.29), Centers for Medicare and Medicaid Services [Internet]. c2015 [cited 2015 Dec 12]. Available from: www.cms.gov.
85. Nelson LS, Lewin NA, Howland MA, Hoffman RS, Goldfrank LR, Flomenbaum NE. Goldfrank's toxicologic emergencies, 9th ed. New York (NY): McGraw Hill; 2011.
86. National Institutes of Health, National Library of Medicine [Internet]. C2015 [cited 2015 Dec 1]. Available from: clinicaltrials.gov.
87. Olivero M. Hospitals Tout Benefits of Hyperbaric Oxygen Therapy [Internet]. 6 Oct 2014 [cited 2015 Nov 11]. Available from: http://www.usnews.com/news/articles/2014/10/06/hospitals-tout-benefits-ofhyperbaric-oxygen-therapy.
88. Oury TD, Ho YS, Piantadosi CA, Crapo JD. Extracellular superoxide dismutase, nitric oxide, and central nervous system O2 toxicity. Proc Natl Acad Sci USA. 1992; 89(20):9715-9719.
89. Pace N, Strajman E, Walker EL. Acceleration of carbon monoxide elimination in man by high pressure oxygen. Science. 1950; 111(2894): 652-654.
90. Piantadosi CA, Tatro LG. Regional H2O2 concentration in rat brain after hyperoxic convulsions. J Appl Physiol. 1990 Nov 69(5):1761-1766.
91. Pilla R, Held HE, Landon CS, Dean JB. High doses of pseudoephedrine hydrochloride accelerate onset of CNS oxygen toxicity seizures in unanesthetized rats. Neuroscience. 2013; 246:391-396.
92. Plafki C, Peters P, Almeling M, Welslau W, Busch R. Complications and side effects of hyperbaric oxygen therapy. Aviat Space Environ Med. 2000; 71(2):119-124.
93. Puglia CD, Loeb GA. Influence of rat brain superoxide dismutase inhibition by diethyldithiocarbamate upon the rate of development of central nervous system oxygen toxicity. Toxicol Appl Pharmacol. 1984; 75(2):258-264.
94. Raman G, Kupelnick B, Chew P, Lau J. A Horizon Scan: Uses of Hyperbaric Oxygen Therapy [Internet]. Rockville (MD): Agency for Healthcare Research and Quality (US); 2006 Oct 05. Available from http://www.ncbi. nlm.nih.gov/books/NBK299143/.
95. Reshef A, Bitterman N, Kerem D. The effect of carbamazepine and ethosuximide on hyperoxic seizures. Epilepsy Res. 1991; 8(2):117-121.
96. Roche CJ, Dantsker D, Samuni U, Friedman JM. Nitrite reductase activity of sol-gel-encapsulated deoxyhemoglobin. Influence of quaternary and tertiary structure. J Biol Chem. 2006; 281(48):36874-36882 Epub 2006 Sep 19.
97. Sanders RW, Katz KD, Suyama J, Akhtar J, O'Toole KS, et al. Seizure during hyperbaric oxygen therapy for carbon monoxide toxicity: a case series and five-year experience. J Emerg Med. 2012; 42(4):e69-72.
98. Sato T, Takeda Y, Hagioka S, Zhang S, Hirakawa M. Changes in nitric oxide production and cerebral blood flow before development of hyperbaric oxygen-induced seizures in rats. Brain Res. 2001; 918(1-2):131-140.
99. Seckin M, Gurgor N, Beckmann YY, Ulukok MD, Suzen A, Basoglu M. Focal status epilepticus induced by hyperbaric oxygen therapy. Neurologist. 2011; 17(1):31-33.
100. Seidel R, Carroll C, Thompson D, Diem RG, Yeboah K, et al. Risk factors for oxygen toxicity seizures in hyperbaric oxygen therapy: case reports from multiple institutions. Undersea Hyperb Med. 2013; 40(6):515-519.
101. Shelton CJ, Doyle MG, Price DJ, Daniels S, Smith EB. The effect of high pressure on glycine-and kainate-sensitive receptor channels expressed in Xenopus oocytes. Proc Biol Sci. 1993; 254(1340):131-137.
102. ShykoffB. Incidence of CNS oxygen toxicity with mild hyperoxia: a literature and data review. Panama City (FL): Navy Experimental Dive Unit; 2013; TA 12-03 NEDU TR 13-03.
103. Singh AK, Banister EW. Relative effects of hyperbaric oxygen on cations and catecholamine metabolism in rats: protection by lithium against seizures. Toxicology. 1981; 22(2):133-147.
104. Thom SR. Hyperbaric oxygen-its mechanisms and efficacy. Plast Reconstr Surg. 2011; 127(Suppl 1):131S-141S.
105. Thom SR. Oxidative stress is fundamental to hyperbaric oxygen therapy. J Appl Physiol (1985). 2009; 106(3):988-995.
106. Thomson L, Paton J. Oxygen toxicity. Paediatr Respir Rev. 2014; 15(2): 120-123.
107. Tibbles PM, Edelsberg JS. Hyperbaric-oxygen therapy. N Engl J Med. 1996;334(25):1642-1648.
108. Torbati D, Church DF, Keller JM, Pryor WA. Free radical generation in the brain precedes hyperbaric oxygen-induced convulsions. Free Radic Biol Med. 1992; 13(2):101-106.
109. Torbati D, Lambertsen CJ. Regional cerebral metabolic rate for glucose during hyperbaric oxygen-induced convulsion. Brain Res. 1983; 279(1-2): 382-386.
110. Tzuk-Shina T, Bitterman N, Harel D. The effect of vigabatrin on central nervous system oxygen toxicity in rats. Eur J Pharmacol. 1991; 202(2):171-175.
111. Vion-Dury J, LeGal La Salle G, Rougier I, Papy JJ. Effects of hyperbaric and hyperoxic conditions on amygdala-kindled seizures in rat. Exp Neurol. 1986; 92(3):513-521.
112. Voronov IB. Brain structures and origin of convulsions caused by high oxygen pressure (HOP). Int J Neuropharmacol. 1964; 3:279-282.
113. Walker J. Hyperbaric oxygen therapy gets more popular as unapproved treatment: use of HBOT to treat autism, brain injury is growing despite a lack of conclusive evidence [Internet]. Wall Street Journal; 5 Jan 2015 [cited 2015 Nov 11]. Available from: http://www.wsj.com/articles/hyperbaric-oxygen-therapy-gets-more-popular-as-unapproved-autismtreatment-1420496506.
114. Walter FG, Chase PB, Fernandez MC, Cameron D, Roe DJ, Wolfson M. Pyridoxine does not prevent hyperbaric oxygen-induced seizures in rats. J Emerg Med. 2006; 31(2):135-138.
115. Wang WJ, Ho XP, Yan YL, Yan TH, Li CL. Intrasynaptosomal free calcium and nitric oxide metabolism in central nervous system oxygen toxicity. Aviat Space Environ Med. 1998; 69(6):551-555.
116. Weaver LK. Phenytoin sodium in oxygen-toxicity-induced seizures. Ann Emerg Med. 1983; 12(1):38-41.
117. Whelan HT, Bajic DM, Karlovits SM, Houle JM, Kindwall EP. Use of cytochrome-P450 mono-oxygenase 2 E1 isozyme inhibitors to delay seizures caused by central nervous system oxygen toxicity. Aviat Space Environ Med. 1998; 69(5):480-485.
118. Witucki P, Duchnick J, Neuman T, Grover I. Incidence of DCS and oxygen toxicity in chamber attendants: a 28-year experience. Undersea Hyperb Med. 2013; 40:345-350.
119. Wood CD. Acetazolamide and CO2 in hyperbaric oxygen toxicity. Undersea Biomed Res. 1982; 9(1):15-20.
120. Wood JD. The role of gamma-aminobutyric acid in the mechanism of seizures. Prog Neurobiol. 1975; 5(1):77-95.
121. Wood JD, Watson WJ, Murray GW. Correlation between decreases in brain gamma-aminobutyric acid levels and susceptibility to convulsions induced by hyperbaric oxygen. J Neurochem. 1969; 16(3):281-287.
122. Wylie DC, Das J, Chakraborty AK. Sensitivity of T cells to antigen and antagonism emerges from differential regulation of the same molecular signaling module. Proc Natl Acad Sci USA. 2007; 104(13): 5533-5538.
123. Xiao X, Wang ZZ, Xu WG, Xiao K, Cai ZY, et al. Cerebral blood flow increase during prolonged hyperbaric oxygen exposure may not be necessary for subsequent convulsion. CNS Neurosci Ther. 2012; 18(11):947-949.
124. Yildiz S, Aktas S, Cimsit M, Ay H, Togrol E. Seizure incidence in 80, 000 patient treatments with hyperbaric oxygen. Aviat Space Environ Med. 2004; 75:992-994.
125. Yoles E, Zurovsky Y, Zarchin N, Mayevsky A. The effect of hyperbaric hyperoxia on brain function in the newborn dog in vivo. Neurol Res. 2000; 22(4):404-408.
126. Zhang C, Bélanger S, Pouliot P, Lesage F. Measurement of local partial pressure of oxygen in the brain tissue under normoxia and epilepsy with phosphorescence lifetime microscopy. PLoS ONE. 2015;10(8): e0135536.